NPR’s Michel Martin speaks with former CDC official Demetre Daskalakis in regards to the absence of a CDC director and the federal government’s potential to reply to public well being threats.
LEILA FADEL, HOST:
The Facilities for Illness Management and Prevention doesn’t have a director. The previous interim director, Jay Bhattacharya, has exceeded the time he was legally allowed to guide the CDC. The White Home has not nominated anybody new to run the general public well being company which predicts and helps management the unfold of illness. Bhattacharya additionally directs the Nationwide Institutes of Well being. The Trump administration says he’ll hold main the CDC, too, simply with out the title.
MICHEL MARTIN, HOST:
We wished to think about what the impression could be from somebody who is aware of the company effectively. So we have known as Dr. Demetre Daskalakis. He was a prime CDC scientist till he resigned final summer time over the firing of the CDC’s final confirmed director. Dr. Daskalakis, thanks a lot for speaking to us.
DEMETRE DASKALAKIS: Thanks a lot for having me.
MARTIN: So it isn’t simply that the director’s chair will likely be – effectively, they are saying it will not be empty, nevertheless it will not be full of a confirmed director. It seems that plenty of management roles at CDC are empty, together with your former place as head of the Nationwide Heart for Immunization and Respiratory Illnesses. And I used to be questioning, does the truth that there aren’t leaders in place at these jobs change what the CDC can do?
DASKALAKIS: So the quick reply is that management vacuums at CDC which might be temporary are one thing that you may take care of. However after they’re this lengthy, what occurs is the ship begins to really feel just a little rudderless, prefer it would not have a captain.
MARTIN: Are you able to give me an instance of how management makes a distinction? Simply say, for instance, in your former division for immunization and respiratory illness.
DASKALAKIS: Certain.
MARTIN: How does the shortage of a frontrunner in an company like that make a distinction?
DASKALAKIS: Yeah, how’s measles? That is in all probability a superb one. In my heart, I’ve measles consultants. However being the chief of the middle implies that you are in a position to contextualize the work that they are doing. So, you already know, when the West Wing calls and says we wish to know what is going on on with measles, they often name the CDC director, who must have connectivity down deeper into the group to have the ability to reply these questions with authority. So that you must have that management, that scientific management, to just remember to’re delivering on what the mission is of your heart and finally of the company. Should you cared about an company so essential to the well being of America, you’d prioritize figuring out a frontrunner and putting in them.
MARTIN: So whereas the CDC is director-less, can the general public belief the information and the analysis popping out of the CDC proper now?
DASKALAKIS: So the issue is, if you cannot belief a few of it, are you able to belief any of it, proper? So I feel it is truthful to say that a few of the issues popping out of CDC round immunization and vaccines, round race and ethnicity, you must take these with of grain of salt now as a result of they have been influenced by ideology. So I feel that on the finish of the day, you must take a look at your clinician. So if in case you have a physician, they’re skilled organizations. And albeit, the native well being departments, whether or not it is state or metropolis or county, as a result of they now have been given the very arduous work of differentiating the sign from noise that is popping out of HHS.
MARTIN: HHS is saying that Dr. Jay Bhattacharya continues to be working the company. He will likely be working the company. He will likely be functioning in that function however with out the title. Does that not offer you any consolation in any respect that the work nonetheless will likely be executed?
DASKALAKIS: I do not know Dr. Bhattacharya personally, so I think about that he has infinite capability. However, you already know, seemingly, he has a big vacuum of leaders at NIH with a really related story, with most of the institutes unstaffed by everlasting leaders – similar to what you are seeing at CDC with the middle administrators and different places of work. So I do not see that it is doable for a human to indefinitely cowl each of those roles and count on that there is going to be success in both.
MARTIN: That’s Dr. Demetre Daskalakis. He was a prime scientist on the CDC till he resigned final summer time. He’s now the chief medical officer of the Callen-Lorde Group Well being Heart in New York. Dr. Daskalakis, thanks a lot for sharing these insights with us.
DASKALAKIS: Thanks a lot.
(SOUNDBITE OF YPPAH’S “SOFT RESET”)
MARTIN: We reached out to the Division of Well being and Human Companies and the White Home for touch upon the management vacancies. HHS spokesperson Andrew Nixon wrote that each the CDC and NIH proceed to meet their missions, and the seek for a brand new CDC director is ongoing.
(SOUNDBITE OF YPPAH’S “SOFT RESET”)
Copyright © 2026 NPR. All rights reserved. Go to our web site phrases of use and permissions pages at www.npr.org for additional data.
Accuracy and availability of NPR transcripts might fluctuate. Transcript textual content could also be revised to right errors or match updates to audio. Audio on npr.org could also be edited after its unique broadcast or publication. The authoritative document of NPR’s programming is the audio document.
